Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
January 6, 1995
Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors
X Zheng, S R Salgia, W B Thompson, et al.
The Journal of Biological Chemistry
|
December 6, 1996
The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells
R Salgia, S Avraham, E Pisick, et al.
Alimentary Pharmacology & Therapeutics
|
December 17, 2009
The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre
A G Singal, M O Rakoski, R Salgia, et al.
The Journal of Biological Chemistry
|
June 2, 2000
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
M Sattler, S Verma, G Shrikhande, et al.
Leukemia & Lymphoma
|
March 14, 1998
Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells
A Astier, S N Manié, S F Law, et al.
The Journal of Biological Chemistry
|
December 8, 1995
CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells
R Salgia, N Uemura, K Okuda, et al.
The Journal of Biological Chemistry
|
March 10, 1995
Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL
R Salgia, J L Li, S H Lo, et al.
Oncogene
|
February 15, 1996
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway
M Sattler, R Salgia, K Okuda, et al.
Experimental Hematology
|
January 1, 1997
Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation
S N Manié, M Sattler, A Astier, et al.
Oncogene
|
August 3, 2000
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
W L Wang, M E Healy, M Sattler, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
January 6, 1995
Design and synthesis of piperidine-3-carboxamides as human platelet aggregation inhibitors
X Zheng, S R Salgia, W B Thompson, et al.
The Journal of Biological Chemistry
|
December 6, 1996
The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells
R Salgia, S Avraham, E Pisick, et al.
Alimentary Pharmacology & Therapeutics
|
December 17, 2009
The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre
A G Singal, M O Rakoski, R Salgia, et al.
The Journal of Biological Chemistry
|
June 2, 2000
The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
M Sattler, S Verma, G Shrikhande, et al.
Leukemia & Lymphoma
|
March 14, 1998
Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells
A Astier, S N Manié, S F Law, et al.
The Journal of Biological Chemistry
|
December 8, 1995
CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells
R Salgia, N Uemura, K Okuda, et al.
The Journal of Biological Chemistry
|
March 10, 1995
Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL
R Salgia, J L Li, S H Lo, et al.
Oncogene
|
February 15, 1996
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway
M Sattler, R Salgia, K Okuda, et al.
Experimental Hematology
|
January 1, 1997
Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation
S N Manié, M Sattler, A Astier, et al.
Oncogene
|
August 3, 2000
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
W L Wang, M E Healy, M Sattler, et al.
Page
of 8